551 related articles for article (PubMed ID: 28409743)
1. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
[TBL] [Abstract][Full Text] [Related]
2. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Mehanna H; Wong WL; McConkey CC; Rahman JK; Robinson M; Hartley AG; Nutting C; Powell N; Al-Booz H; Robinson M; Junor E; Rizwanullah M; von Zeidler SV; Wieshmann H; Hulme C; Smith AF; Hall P; Dunn J;
N Engl J Med; 2016 Apr; 374(15):1444-54. PubMed ID: 27007578
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
[TBL] [Abstract][Full Text] [Related]
4. Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
Earl H; Hiller L; Vallier AL; Loi S; McAdam K; Hughes-Davies L; Rea D; Howe D; Raynes K; Higgins HB; Wilcox M; Plummer C; Mahler-Araujo B; Provenzano E; Chhabra A; Gasson S; Balmer C; Abraham JE; Caldas C; Hall P; Shinkins B; McCabe C; Hulme C; Miles D; Wardley AM; Cameron DA; Dunn JA
Health Technol Assess; 2020 Aug; 24(40):1-190. PubMed ID: 32880572
[TBL] [Abstract][Full Text] [Related]
5. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
[TBL] [Abstract][Full Text] [Related]
6. Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
Paleri V; Patterson J; Rousseau N; Moloney E; Craig D; Tzelis D; Wilkinson N; Franks J; Hynes AM; Heaven B; Hamilton D; Guerrero-Urbano T; Donnelly R; Barclay S; Rapley T; Stocken D
Health Technol Assess; 2018 Apr; 22(16):1-144. PubMed ID: 29650060
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
[TBL] [Abstract][Full Text] [Related]
8. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
[TBL] [Abstract][Full Text] [Related]
9. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
14. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
[TBL] [Abstract][Full Text] [Related]
15. Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation.
Sharples L; Everett C; Singh J; Mills C; Spyt T; Abu-Omar Y; Fynn S; Thorpe B; Stoneman V; Goddard H; Fox-Rushby J; Nashef S
Health Technol Assess; 2018 Apr; 22(19):1-132. PubMed ID: 29701167
[TBL] [Abstract][Full Text] [Related]
16. A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
Fu TS; Scheffler P; Forner D; Noel CW; Huang SH; Gilbert RW; Goldstein DP; O'Sullivan B; Mehanna HM; Waldron J; de Almeida JR
Cancer; 2021 Sep; 127(18):3372-3380. PubMed ID: 34062618
[TBL] [Abstract][Full Text] [Related]
17. Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT.
Dasgupta R; Cameron S; Aucott L; MacLennan G; Kilonzo MM; Lam TB; Thomas R; Norrie J; McDonald A; Anson K; N'Dow J; Burgess N; Clark CT; Keeley FX; MacLennan SJ; Starr K; McClinton S
Health Technol Assess; 2022 Mar; 26(19):1-70. PubMed ID: 35301982
[TBL] [Abstract][Full Text] [Related]
18. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.
Heer R; Lewis R; Duncan A; Penegar S; Vadiveloo T; Clark E; Yu G; Mariappan P; Cresswell J; McGrath J; N'Dow J; Nabi G; Mostafid H; Kelly J; Ramsay C; Lazarowicz H; Allan A; Breckons M; Campbell K; Campbell L; Feber A; McDonald A; Norrie J; Orozco-Leal G; Rice S; Tandogdu Z; Taylor E; Wilson L; Vale L; MacLennan G; Hall E
Health Technol Assess; 2022 Oct; 26(40):1-144. PubMed ID: 36300825
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling.
Gilbert FJ; Harris S; Miles KA; Weir-McCall JR; Qureshi NR; Rintoul RC; Dizdarevic S; Pike L; Sinclair D; Shah A; Eaton R; Clegg A; Benedetto V; Hill JE; Cook A; Tzelis D; Vale L; Brindle L; Madden J; Cozens K; Little LA; Eichhorst K; Moate P; McClement C; Peebles C; Banerjee A; Han S; Poon FW; Groves AM; Kurban L; Frew AJ; Callister ME; Crosbie P; Gleeson FV; Karunasaagarar K; Kankam O; George S
Health Technol Assess; 2022 Mar; 26(17):1-180. PubMed ID: 35289267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
